Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. - Wikidata - awgldk - TriplyDB

Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.

Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.

http://www.wikidata.org/entity/Q52943812

about

Occupational exposure to nanomedical applications Magneto acoustic tomography with short pulsed magnetic field for in-vivo imaging of magnetic iron oxide nanoparticles T₁ estimation for aqueous iron oxide nanoparticle suspensions using a variable flip angle SWIFT sequence.Quantifying iron-oxide nanoparticles at high concentration based on longitudinal relaxation using a three-dimensional SWIFT Look-Locker sequence Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells Effect of Fe(3)O(4)-magnetic nanoparticles on acute exercise enhanced KCNQ(1) expression in mouse cardiac muscle Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells In Vivo Imaging and Quantification of Iron Oxide Nanoparticle Uptake and Biodistribution Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy.Analysis of the distribution of magnetic fluid inside tumors by a giant magnetoresistance probe.Impact of magnetic field parameters and iron oxide nanoparticle properties on heat generation for use in magnetic hyperthermia Magnetic fluid hyperthermia induced by radiofrequency capacitive field for the treatment of transplanted subcutaneous tumors in rats Evolving technology for thermal therapy of cancer.In Vitro Capture of Small Ferrous Particles with a Magnetic Filtration Device Designed for Intravascular Use with Intraarterial Chemotherapy: Proof-of-Concept Study Magnetic nanoparticles and their applications in medicine.Applications of nanoparticles in the detection and treatment of kidney diseases Practical considerations for maximizing heat production in a novel thermobrachytherapy seed prototype.Nanoimaging and neurological surgery.Targeted nanotheranostics for personalized cancer therapy.Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia.Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.A novel strategy combining magnetic particle hyperthermia pulses with enhanced performance binary ferrite carriers for effective in vitro manipulation of primary human osteogenic sarcoma cells.Identification of infusion strategy for achieving repeatable nanoparticle distribution and quantification of thermal dosage using micro-CT Hounsfield unit in magnetic nanoparticle hyperthermia.Magnetically guided capsule endoscopy.Numerical assessment of a criterion for the optimal choice of the operative conditions in magnetic nanoparticle hyperthermia on a realistic model of the human head.Carbon nanotube based biomedical agents for heating, temperature sensoring and drug delivery.Hybrid biofunctional nanostructures as stimuli-responsive catalytic systems Carbon Nanotubes Filled with Ferromagnetic Materials.Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy.Accounting for biological aggregation in heating and imaging of magnetic nanoparticles.A carbon-wrapped nanoscaled thermometer for temperature control in biological environments.Optimizing magnetic nanoparticle based thermal therapies within the physical limits of heating.New insights into the heating mechanisms and self-regulating abilities of manganite perovskite nanoparticles suitable for magnetic fluid hyperthermia.Practical methods for generating alternating magnetic fields for biomedical research.Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy, and application in humans.Novel nanoparticles with Cr3+ substituted ferrite for self-regulating temperature hyperthermia.18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.Establishing the overlap of IONP quantification with echo and echoless MR relaxation mapping.Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique.

P2860

Q23923393-92608ACD-7C6E-4D4F-8716-753BCCE3D4AA Q30359959-61F97AE8-6BA6-4A64-9B25-9C765E5D7ABC Q30652478-446A717E-B96A-4644-99DD-F7D6A69C4739 Q30784889-78B55787-D254-4D53-B723-5B0124BD50CD Q33474444-0A65E8C5-FC07-43B1-B238-4334F331DB27 Q33738469-48FD6C89-0AB4-42DC-A626-CDA028316A84 Q34121001-DD437683-60E2-4DF8-A1E3-B6806586A27F Q34279054-1278E14A-74A9-4FE4-A192-E72FC6E3A73E Q34766341-7409C28F-81D4-49BD-BF6E-FF2A6D8DC456 Q35060481-A8882909-3C56-414F-A244-4F4E9E60F387 Q35575720-A2B6CF5A-79B0-4805-83F7-1AFEE16C7BDC Q36224797-37708DD2-9516-4366-A5B3-78CE289521C0 Q36336652-7A7B1BD2-9223-4346-AF9A-463D4D272722 Q36624437-4A71A36F-C978-4919-A7A3-431D0572F61E Q36917874-45662D2A-68D8-4AC9-9AE0-7B83CB8E36CE Q37298541-A29058D5-CE3B-403D-AD33-824BAF3E976B Q37505106-A11FDB6D-0BE6-40D6-97E3-9037B46AC1F2 Q37776462-1E02C15A-22B1-4576-B9B4-8FFEC25DB8D9 Q38054793-4A88855C-1BED-4438-BA3F-763E11B8717C Q38133825-69B22458-16B6-4586-8055-EA142C526680 Q38260733-1338E278-F8DA-427D-9114-707164DBD11D Q38756646-5B9AD92A-C1D6-4696-879D-8431710CAFB6 Q38804366-66485686-9AFD-4164-A2A9-F44B9FBF24E4 Q39258538-916888E0-63B5-4A30-975A-68436C2D6A13 Q39705494-BB3BA55B-C1C5-4218-909A-EA4CD08EC6DD Q40407175-07F83C15-11BA-431F-A25F-3737D0A1C485 Q41825599-0B9D4C38-4C5B-4465-8D42-BA999481C1A7 Q41854865-62E7B0A3-CEFF-42F2-A88F-95ED19E57FE4 Q42060733-FE9E8DC3-9741-4080-B4E3-7FD10DE86A99 Q42686801-E70C92AF-1E15-4B70-90B8-90EF8A76DFDB Q42974606-D81C6529-4050-42BD-A2B3-C78608E8DA3C Q45187675-6519BE32-A177-42FB-9F27-2FCDA1956B9D Q46045474-04BD2EFB-EBD6-48BF-83A7-4776448D242B Q47676878-DA6387D5-D4BB-4FF9-BF13-1B6765C6BD63 Q47704032-430D789E-2B93-410E-9764-5B11B025B474 Q47721799-F5705F33-EF9D-454F-8279-EE70EEDE87B1 Q47903190-EB68E840-3CC2-49F8-9797-C26AC76F2D34 Q48509442-EE1E1EF1-DBD9-45B1-BE09-36C537801EAD Q48627780-C16705F1-A85A-4173-AF78-2DC96308E729 Q48751482-A1874431-2CA0-4875-8E9A-21F8FAD395CE

P2860

Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.

http://www.wikidata.org/entity/Q52943812

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Description and characterizati ...... l magnetic fluid hyperthermia.

@en

Description and characterizati ...... l magnetic fluid hyperthermia.

@nl

type

label

Description and characterizati ...... l magnetic fluid hyperthermia.

@en

Description and characterizati ...... l magnetic fluid hyperthermia.

@nl

prefLabel

Description and characterizati ...... l magnetic fluid hyperthermia.

@en

Description and characterizati ...... l magnetic fluid hyperthermia.

@nl

P1433

Q52943812-C7B59B2B-E566-4F7B-B3A3-B21C257D6D23

P1476

Q52943812-193BDFBF-2895-4F70-B40F-FFCC27BD8391

P2093

Q52943812-020FDD05-EC03-4878-97D2-3018C4EB61A3

Q52943812-375314F3-3FCF-4DF0-ABD1-B61596FB6A9C

Q52943812-4A85DAC9-4AD2-43A5-AF1B-AB1690FFE5BC

Q52943812-64012243-B27A-4561-BAF0-2C68C475A7C2

Q52943812-9FE73549-EDFB-4170-B120-795166F81470

Q52943812-A897DFD1-14AD-4BF2-BA9D-AE470DB72FD9

Q52943812-B698598E-3909-45C8-B73D-F0ADA6277900

Q52943812-BA499B33-707C-4C93-9113-7BEE1BD95351

Q52943812-F95239C6-FEC8-453C-A211-39AB6E7D9188

P2860

Q52943812-3A767E00-225F-4E7F-82F5-3433C0DDB7B3

Q52943812-540B0E36-B2E6-48D3-8346-CC1A88E658D1

Q52943812-622BA108-F3DD-4152-B50A-9FDDCAB83947

Q52943812-66CEBAD4-D9C2-403B-8EA9-258B6B8858F5

Q52943812-DE07A2F8-6B02-4952-B898-305FD72FD28B

P304

Q52943812-70E6F8C7-5265-49B1-9B2D-5D5CA6CAE5ED

P31

Q52943812-B1A51C5B-CF80-4FD9-A7B5-519BC0B00A26

P356

Q52943812-94CAB3A9-5DED-4DB9-8DDE-7E67D5DAA079

P407

Q52943812-4430D439-37BE-4645-A269-745370D7F8C5

P433

Q52943812-0EA54A25-EC3A-4F31-8B75-293DB59E1E42

P478

Q52943812-0FD3E993-A2DA-4651-8588-F90DB0517E2E

P50

Q52943812-CF9E27B8-6C0A-4EF4-B4E7-3D66DDB4A9DA

P577

Q52943812-24CF1437-1DC3-494D-8901-0975F3DAA88F

P5875

Q52943812-C769AE97-CB5A-4946-9E35-EEF84C8F0FFC

P698

Q52943812-11E924AF-CB6B-4C63-8DAF-75F9FE645423

P356

P1433

Medical Physics

P1476

Description and characterizati ...... al magnetic fluid hyperthermia

@en

P2093

Andreas Jordan

http://www.w3.org/2001/XMLSchema#string

Annelie Feussner

http://www.w3.org/2001/XMLSchema#string

Beate Rau

http://www.w3.org/2001/XMLSchema#string

Bert Hildebrandt

http://www.w3.org/2001/XMLSchema#string

Jens Ricke

http://www.w3.org/2001/XMLSchema#string

Norbert Waldöfner

http://www.w3.org/2001/XMLSchema#string

Peter Wust

http://www.w3.org/2001/XMLSchema#string

Regina Scholz

http://www.w3.org/2001/XMLSchema#string

Volker Brüss

http://www.w3.org/2001/XMLSchema#string

P2860

Ablative therapy for liver tumours.

Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations.

The Dutch Deep Hyperthermia Trial: results in cervical cancer.

Hyperthermia in combined treatment of cancer.

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma

P304

1444-1451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1118/1.1748629

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234991213

http://www.w3.org/2001/XMLSchema#string

P698

15259647

http://www.w3.org/2001/XMLSchema#string